Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease ...

“Genetic variants associated with larger brain volumes in key brain regions also increase the risk of Parkinson’s disease, while variants linked to smaller brain volumes in key regions are ...

Parkinson's disease and attention deficit hyperactivity disorder (ADHD) may be genetically linked, with effects on brain volume, a large study has found. "There is strong evidence that ADHD and ...

The U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD). Vyalev is the first and only ...

Although brain-implanted electrodes do help minimize the effects of Parkinson's disease and other neurological disorders, implanting and activating those electrodes can be a tricky process.

The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...

Researchers have found that a compound derived from used coffee beans shows promise in protecting ... diseases include Alzheimer's disease, Parkinson's disease, prion disease, Amyotrophic lateral ...

Photo of John Stapleton who has revealed his diagnosis with Parkinson's disease. Credit ... her inability to do things like open a can of beans or peel a potato.“Believe it or not, I’m ...

Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...